Overall verdict
Neutral
4.7/10
1-year performance
+46.54%
Score breakdown
Up 46.5% over 1 year, 71% of the 52-week range.
Strongest: Financial strength 7.8/10. Weakest: Profitability 0.0/10.
19 analysts, target +0.1% vs the price.
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
Sector
Health Care
Industry
Health Care Providers and Services
Primary listing
Nyse
United States
CEO
Joseph Zubretsky
Founded
1999
Employees
19 000
Revenue / employee
2.4M USD
Next earnings
February 10, 2027 (estimated)
Institutional holders
- FMR LLC2.71%
- GEODE CAPITAL MANAGEMENT, LLC1.87%
- Bank of New York Mellon Corp0.72%
- Rest of the register94.70%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
244.89 USD
52-week low
121.06 USD
1-year performance
46.54%
Rising
Year-to-date performance
20.13%
Rising
Drawdown
-14.65%
Mild pullback
Position in the 52-week range
71% of range
Against the world ETF
Over 23 years, from July 2003 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned more, but shaking 2.9 times harder: for the risk taken, the ETF paid better.
$10,000 placed at the end of July 2003 are worth today
| Molina Healthcare | $129,608 |
| World ETF | $81,686 |
| S&P 500 | $116,117 |
| Risk-free placement | $15,027 |
The risk
- Shaking:the share moves 2.9 times as much as the world ETF.
- Worst fall:-71Â % between March 2024 and February 2026. $10,000 placed at the top fell to $2,924. The world ETF, at worst: -53Â %. The share has not returned to its high yet.
Molina Healthcare earned more than the world ETF since 2003
Value of $10,000 placed at the end of July 2003, dividends reinvested, in dollars
- Molina Healthcare: $129,608
- World ETF: $81,686
- S&P 500: $116,117
- Risk-free placement: $15,027
Share price without dividends; the world ETF and the index reinvest theirs. A dividend payer is therefore understated here.
Based on past performance. This is not a recommendation.
Range: 298.85 USD - 355.39 USD (comparables only)
The price implies growth of 15.87% per year; the company grows at -4.51%.
Gross margin 5.2%, the company loses 0.1% of its revenue, ROIC -0.6%, ROE -1.2%.
Net margin
-0.11%
Negative
Sector 1.68%|S&P 13.40%
Gross margin
5.22%
Low
Return on equity (ROE)
-1.15%
Negative
Sector 10.99%|S&P 17.06%
Return on invested capital (ROIC)
-0.59%
Negative
Free cash flow margin (FCF)
0.54%
Low
Margin stability
0.8 pts
Very steady
Revenue to net income
Growth
1.8/10Revenue down 3.4% over 1 year, 18.7% a year over 5, EPS -4.5% a year over 5.
Revenue (trailing 12 months)
44.1Md USD
Revenue growth (1y)
-3.44%
Declining
Revenue growth (3y)
42.07%
Solid
EPS growth (1y)
-50.96%
Declining
EPS CAGR (5y)
-4.51%
Declining
EPS revisions (3 months)
0.62%
Revised up
Valuation
3.7/10The company loses money, so no valuation multiple can be read: a negative P/E is not a discount.
P/E (TTM)
—
N/A (loss)
Sector 33.5x|S&P 23.6x
Forward P/E
60.8x
Expensive
EV / EBITDA
10.7x
Cheap
Sector 18.5x|S&P 15.5x
PEG
—
Sector -0.20|S&P 0.91
Fair value (reverse DCF)
327.12 USD
Deeply undervalued
Market cap
10.9Md USD
Financial strength
7.8/10Cash covers 113.4% of the debt, net debt/EBITDA -22.1x.
Net debt / EBITDA
-22.1x
Net cash
Gearing (net debt / equity)
-12.73%
Net cash
Cash
4.5Md USD
Cash / market cap
41.05%
Very solid
Cash / total debt
113.39%
Net cash
Interest coverage
0.8x
Stretched
Net debt
-529M USD
Equity
4.2Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 206.35 USD
- MM20209.19
- MM50202.18
- MM200185.43
- RSI 1450.0
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+1.48%
200-day average slope, 3 months
+7.23%
50-day average slope, 1 month
+2.05%
Price structure
Lower lows
Bullish RSI divergence
Yes
20-day volatility
3.10 % per day
Volatility change
+21.48%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 3.44 (7) | 5.27 (19) | 44 742 (16) | 720 (10) | 161 (7) |
| 2027 | 9.54 (6) | 9.54 (19) | 47 629 (15) | 1 019 (10) | 504 (7) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 5, 2026.
Same sub-industry: 10 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PGNY | 7.2 | 7.5 | 2.7Md USD | 33.5x | 6.8 % | 8.9 % | 17.8 % | -3.1x | 6.7 % | 53.4 % | ||
| 2 | HQY | 7.0 | 6.8 | 8.5Md USD | 37.2x | 17.4 % | 7.6 % | 7.7 % | 1.4x | 5.7 % | 3.4 % | ||
| 3 | ELV | 6.8 | 6.7 | 92.8Md USD | 18.3x | 2.5 % | 1.4 % | 6.8 % | 3.0x | 7.0 % | 40.0 % | ||
| 4 | UNH | 6.8 | 6.7 | 361Md USD | 23.0x | 3.5 % | -0.4 % | 9.5 % | 1.8x | 6.3 % | 24.6 % | ||
| 5 | SAUD3 | 6.4 | 5.9 | 8.4Md USD | 16.8x | 10.6 % | 1213.1 % | 10.4 % | -0.3x | 1.5 % | 36.5 % | ||
| 6 | CNC | 5.8 | 5.8 | 34.9Md USD | 24.2x | 0.7 % | 1.9 % | 3.8 % | -1.4x | 11.3 % | 102.9 % | ||
| 7 | HUM | 4.9 | 3.5 | 53.6Md USD | 43.4x | 0.8 % | 26.1 % | 4.1 % | -2.2x | 5.9 % | 86.0 % | ||
| 8 | MOH | 4.7 | 2.8 | 10.9Md USD | Not meaningful (loss) | -0.1 % | -3.4 % | -0.6 % | -22.1x | 2.2 % | 46.5 % | ||
| 9 | CLOV | 4.3 | 1.9 | 2.6Md USD | 263.0x | 0.5 % | 52.9 % | — | — | — | 91.2 % |
